Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism

Clinical trial NCT06362746 · RECRUITING

Trial details

NCT number: NCT06362746
Sponsor: Supergene, LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Embolism

Start date: 2024-05-23
Primary completion: 2028-06-01
Enrollment: 486

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.